Teva Pharmaceutical Industries Ltd. TEVA shares were trading up about 6.5 percent over the past month entering Monday’s open, and the Vetr community has upgraded the company from 4 to 4.5 stars. Teva’s uptrend began at the start of July, right around when the company come out with a September order of 2,000 calls at a $0.98 asking price.
See how crowd sourced ratings can help predict the market?
Vetr members have given Teva a Strong Buy rating and $60.03 price target. This price target is slightly higher than the $69.13 price target from professional analysts. The company is trading around $53.60.
Of all Vetr raters, 100 percent believe traders and investors should buy Teva stock.
For Vetr’s full analysis of Teva, go here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
